Erythromycin Ethylsuccinate Granule, For Suspension
Product Images NDC 62559-440

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Erythromycin Ethylsuccinate (NDC 62559-440). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ani-logo (Ani Logo)

FDA Label Image

Image 01

This text provides directions for preparing an oral suspension medication containing erythromycin ethylsuccinate. The medication should be stored at controlled room temperature, then refrigerated after mixing and used within ten days. It can be taken without regards to meals, and patients should shake the bottle well before use. The text also provides the usual dose for children. The medication is prescription-only, and it is manufactured by a company called Aurobindo Pharmaceuticals, Inc.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.